Richard Barker, D.Phil, MA - Director
Dr. Barker is currently the director general of the Association of the British Pharmaceutical Industry ("ABPI"). Prior to joining ABPI, Dr. Barker was the chairman and chief executive officer of Molecular Staging Inc., founder and president of New Medicine Partners, chief executive officer of iKnowMed, chief executive officer of Chiron Diagnostics Ltd., general manager of IBM's Worldwide Healthcare Solutions division, and leader of McKinsey & Company's European healthcare practice. He is currently a board member of the European Federation of Pharmaceutical Manufacturers and Associations and council member of the International Federation of Pharmaceutical Manufacturers and Associations. Dr. Barker also serves on the board of directors of Adlyfe Inc., a company specializing in protein misfolding diseases. Dr. Barker's academic background includes research in biological magnetic resonance at the Oxford University, Leeds University and the University of Munich. He holds a Doctorate of Philosophy in biophysics and a Master of Arts in chemistry from Oxford University.
W. John Meekison, BA, CIM, P. Log - Chief Financial Officer
John Meekison has over 15 years experience as an investment banker
specializing in life sciences at Loewen, Ondaatje, McCutcheon Limited,
Haywood Securities Inc., Dlouhy Merchant Group Inc. and Pacific
International Securities Inc. As a financier, Mr. Meekison has raised
equity capital fo
|SOURCE Beanstalk Capital Ltd.|
Copyright©2007 PR Newswire.
All rights reserved